A Breakthrough in Hydrogel Technology

Current Problem


Diabetic ulcers are costly, chronic wounds that often result in limb amputations. Diabetic ulcers are estimated to cost $78 billion per year in the United States alone, they lead to 80% of non-traumatic amputations, and every 20 seconds a limb is lost to a diabetic ulcer. Better treatment options are desperately needed. Chronic wounds suffer from high levels of inflammation which impairs the natural healing process. Wound dressings currently available do not address the inflammation problem. Currently available wound dressings are also not capable of sustained therapeutic delivery.

Our Technology


GelSana’s novel hydrogel technology helps reduce inflammation at the wound site, providing decreased healing time. Faster healing reduces the risk of infection and amputation. Our novel hydrogels have superior handling properties. GelSana hydrogels are also capable of providing sustained release of therapeutics to the wound bed over time, promoting even faster healing.

Syringe hydrogel application

Hydrogels with novel chemistry that gently adhere to surrounding healthy tissues while protecting the wound, that reduce inflammation to lead to faster healing, and that are capable of sustained drug delivery over time to the wound bed.